期刊
NATURE
卷 510, 期 7505, 页码 422-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature13263
关键词
-
资金
- Biotechnology and Biological Sciences Research Council
- Wellcome Trust
- European Research Council
- Medical Research Council
- Oxford NIHR Biomedical Research Unit
- Cancer Research UK
- Arthritis Research UK
- Bayer Healthcare
- Rosetree Foundation
- Slovenian Academy of Sciences and Arts
- Abbvie
- Boehringer Ingelheim
- Canadian Institutes for Health Research
- Canadian Foundation for Innovation
- Eli Lilly
- Genome Canada
- GlaxoSmithKline
- Ontario Ministry of Economic Development and Innovation
- Janssen
- Novartis Research Foundation
- Pfizer
- Takeda
- BBSRC [BB/L009846/1, BB/J003018/1, BB/L004275/1, BB/J018643/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/C518230/1, BB/J003018/1, BB/J018643/1, BB/L009846/1, BB/L004275/1] Funding Source: researchfish
- Cancer Research UK [6947] Funding Source: researchfish
2-Oxoglutarate (2OG)-dependent oxygenases have important roles in the regulation of gene expression via demethylation of N-methylated chromatin components(1,2) and in the hydroxylation of transcription factors(3) and splicing factor proteins(4). Recently, 2OG-dependent oxygenases that catalyse hydroxylation of transferRNA(5-7) and ribosomal proteins(8) have been shown to be important in translation relating to cellular growth, T(H)17-cell differentiation and translational accuracy(9-12). The finding that ribosomal oxygenases (ROXs) occur in organisms ranging from prokaryotes to humans(8) raises questions as to their structural and evolutionary relationships. In Escherichia coli, YcfD catalyses arginine hydroxylation in the ribosomal protein L16; in humans, MYC-induced nuclear antigen (MINA53; also known as MINA) and nucleolar protein 66 (NO66) catalyse histidine hydroxylation in the ribosomal proteins RPL27A and RPL8, respectively. The functional assignments of ROXs open therapeutic possibilities via either ROX inhibition or targeting of differentially modified ribosomes. Despite differences in the residue and protein selectivities of prokaryotic and eukaryotic ROXs, comparison of the crystal structures of E. coli YcfD and Rhodothermus marinus YcfD with those of human MINA53 and NO66 reveals highly conserved folds and novel dimerization modes defining a new structural subfamily of 2OG-dependent oxygenases. ROX structures with and without their substrates support their functional assignments as hydroxylases but not demethylases, and reveal how the subfamily has evolved to catalyse the hydroxylation of different residue side chains of ribosomal proteins. Comparison of ROX crystal structures with those of other JmjC-domain-containing hydroxylases, including the hypoxia-inducible factor asparaginyl hydroxylase FIH and histone N-epsilon -methyl lysine demethylases, identifies branch points in 2OG-dependent oxygenase evolution and distinguishes between JmjC-containing hydroxylases and demethylases catalysing modifications of translational and transcriptional machinery. The structures reveal that new protein hydroxylation activities can evolve by changing the coordination position from which the iron-bound substrate-oxidizing species reacts. This coordination flexibility has probably contributed to the evolution of the wide range of reactions catalysed by oxygenases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据